Table 2.
Multivariable logistic regression model for new hypertension after AKI
| Covariate | Odds ratio | 95% CI | p-value |
|---|---|---|---|
| Sex | 0.96 | 0.55–1.68 | 0.898 |
| BMI | 1.01 | 0.95–1.07 | 0.776 |
| Age at AKI diagnosis | 1.00 | 0.99–1.01 | 0.491 |
| Family history of kidney disease | 1.21 | 0.66–2.21 | 0.543 |
| Prematurity | 0.31 | 0.13–0.72 | 0.008 |
| Congenital heart disease | 2.27 | 1.17–4.45 | 0.015 |
| Malignancy | 0.74 | 0.29–1.76 | 0.510 |
| Previous AKI | 1.32 | 0.53–3.12 | 0.539 |
| CKD | 1.91 | 0.58–5.67 | 0.257 |
| Solid organ transplant | 5.48 | 2.41–12.79 | <0.001 |
| AKI stage 2 vs stage 1 | 1.49 | 0.59–4.15 | 0.413 |
| AKI stage 3 vs stage 1 | 2.50 | 0.98–7.11 | 0.066 |
| Duration of AKI | 1.04 | 0.89–1.21 | 0.628 |
| AKD | 2.63 | 1.41–5.03 | 0.003 |
| Need for kidney replacement therapy | 1.84 | 0.78–4.29 | 0.159 |